Long-acting contraceptive designed to be self-administered via microneedle patch

FHI 360 scientists and researchers at the Georgia Institute of Technology report on a long-acting contraceptive using microneedle skin patch technology to provide a new family planning option. Gregory S. Kopf, Director of Research and Development for Contraceptive Technology Innovation at FHI 360 said, “This self-administered long-acting contraceptive will afford women discreet and convenient control over their fertility, leading to a positive impact on public health by reducing both unwanted and unintended pregnancies.”